Search clinical trials for: Rituxan® (rituximab)
Total 16932 results
-
University of Wisconsin, MadisonGenentech, Inc.WithdrawnEnd Stage Renal DiseaseUnited States
-
PETHEMA FoundationCompletedAcute Lymphoblastic Leukemia | Burkitt's LymphomaSpain
-
Genentech, Inc.CompletedMultiple SclerosisUnited States
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedLymphomaUnited States, Puerto Rico, South Africa
-
BiogenCompletedNon-Hodgkin's LymphomaSweden, Czech Republic, France, Russian Federation, Turkey, United Kingdom, Germany, Lithuania, Romania, United States, Austria
-
Rambam Health Care CampusTechnion, Israel Institute of TechnologyUnknown
-
University of Alabama at BirminghamCompletedPurpura, Thrombocytopenic, IdiopathicUnited States
-
Charite University, Berlin, GermanyHoffmann-La RocheUnknownAnkylosing SpondylitisGermany
-
National Institute of Allergy and Infectious Diseases...Immune Tolerance Network (ITN)CompletedKidney Failure, Chronic | Kidney TransplantationUnited States
-
M.D. Anderson Cancer CenterCompletedLymphoma | Leukemia | MyelomaUnited States
-
Loxo Oncology, Inc.Eli Lilly and CompanyRecruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaCanada, United States, Korea, Republic of, Australia, China, Taiwan, Spain, Italy, United Kingdom, Japan, Ireland, Denmark, Hungary, Poland, Czechia, France, Israel, Singapore, Belgium, Sweden, Germany, Switzerland
-
Fernando FervenzaGenentech, Inc.; Biogen; National Center for Research Resources (NCRR)Terminated
-
University of NebraskaNational Cancer Institute (NCI); Genentech, Inc.Completed
-
National Cancer Institute (NCI)TerminatedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Marginal Zone Lymphoma | Splenic Marginal Zone... and other conditionsUnited States
-
University of Wisconsin, MadisonCompleted
-
M.D. Anderson Cancer CenterLeadiant Biosciences, Inc.CompletedLeukemia, Lymphocytic, AcuteUnited States
-
University of GiessenCompletedMarginal Zone Lymphomas | Non-Hodgkin Lymphomas | Follicular Lymphomas | Immunocytomas | Lymphocytic LymphomasGermany
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Acute Lymphoblastic Leukemia | Refractory Acute Lymphoblastic Leukemia | Recurrent Burkitt Lymphoma | AIDS-Related Burkitt Lymphoma | Atypical Burkitt/Burkitt-Like Lymphoma | High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements | High Grade B-Cell Lymphoma With MYC, BCL2... and other conditionsUnited States
-
National Cancer Institute (NCI)Active, not recruitingAnn Arbor Stage II Diffuse Large B-Cell Lymphoma | Ann Arbor Stage III Diffuse Large B-Cell Lymphoma | Ann Arbor Stage IV Diffuse Large B-Cell LymphomaUnited States
-
French Innovative Leukemia OrganisationMundipharma Pte Ltd.; Janssen, LPCompleted
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedLymphomaUnited States
-
Lymphoma Study AssociationAmgenTerminatedDiffuse Large Cell LymphomaFrance, Belgium, Switzerland
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedLymphomaUnited States, Canada
-
Dong-A University HospitalCompleted
-
University of California, San FranciscoCompletedLymphoma | Brain and Central Nervous System Tumors
-
Assistance Publique - Hôpitaux de ParisCompletedThrombotic Thrombocytopenic PurpuraFrance
-
Neufeld, Ellis J, MD, PhDGenentech, Inc.; Biogen; Glaser Pediatric Research Network; Terrana ITP Research...CompletedImmune Thrombocytopenic Purpura (ITP) | Idiopathic Thrombocytopenic Purpura (ITP)United States
-
National Pediatric Neuroinflammation Organization...Genentech, Inc.CompletedAtaxia | Myoclonus | Opsoclonus-myoclonus Syndrome | OpsoclonusUnited States
-
Gustave Roussy, Cancer Campus, Grand ParisUnknown
-
Stanford UniversityCompleted
-
University Hospital ErlangenCompletedLymphoma | LeukemiaGermany, Switzerland
-
CelltrionCompletedRheumatoid ArthritisKorea, Republic of
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)TerminatedLymphomaUnited States
-
Swiss Group for Clinical Cancer ResearchCompleted
-
BiogenCompletedLow-Grade or Follicular B-Cell Non-Hodgkin's LymphomaUnited States, Canada
-
Acerta Pharma BVActive, not recruitingChronic Lymphocytic Leukemia | Prolymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
BiogenTerminated
-
Seoul National University HospitalGyeongsang National University Hospital; Hallym University Medical Center; Kyunghee...TerminatedCD20-positive Non-Hodgkin LymphomaKorea, Republic of
-
Papworth Hospital NHS Foundation TrustCompletedMyocardial Infarction | Inflammation | Ischemic Heart DiseaseUnited Kingdom
-
Swiss Group for Clinical Cancer ResearchCompletedLymphomaSwitzerland, South Africa, Italy, Brazil, North Macedonia, Serbia, Slovakia
-
Genentech, Inc.CompletedNon-Hodgkin's Lymphoma, Chronic Lymphocytic LeukemiaUnited States
-
Korea Cancer Center HospitalUnknownRelapsed or Refractory Follicular Lymphoma or Mantle Cell LymphomaKorea, Republic of
-
Korea Cancer Center HospitalUnknownRelapsed or Refractory Marginal Zone B-cell LymphomaKorea, Republic of
-
Masonic Cancer Center, University of MinnesotaNational Cancer Institute (NCI)Terminated
-
Andres J. M. FerreriCompletedOcular Adnexal Mucosa-Associated Lymphoid Tissue LymphomaItaly
-
Beijing Friendship HospitalRecruitingChronic Active Epstein-Barr Virus Infection | Secondary Hemophagocytic LymphohistiocytosisChina
-
Cogent Biosciences, Inc.Terminated
-
Cogent Biosciences, Inc.Completed
-
Genentech, Inc.Completed
-
Genentech, Inc.Completed